Qualitative and Quantitative Evaluation of Abdominal Fat and Muscle Tissue Volume in Patients with Ankylosing Spondylitis and Investigation of Their Possible Effects on Biological Agent Treatment Response Qualitative und quantitative Analyse des abdominalen Fettund Muskelgewebes bei ankylosierender Spondylitis: Einfluss auf das Ansprechen auf Biologika


Kastan N., ERDEM TOSLAK İ., YAVUZ A., BAKIRCI S.

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren, 2026 (SCI-Expanded, Scopus)

Özet

Purpose This study investigates the relationship between sarcopenia index (SMI), quantitative muscle and adipose tissue parameters obtained from abdominal CT, and treatment response to biological agents in patients with ankylosing spondylitis (AS). Materials and Methods In this retrospective study, 62 patients (May 2015–May 2024) with an initial diagnosis of AS and available abdominal CT scans at the L2 vertebral level were included. Quantitative parameters including visceral adipose tissue (VAT, cm2), subcutaneous adipose tissue (SAT, cm2), total abdominal muscle area (TAMA), psoas muscle area (PsoA), sarcopenia index (SMI), and tissue attenuation values (HU) were measured. Changes in scores after biological therapy based on the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) were used to assess treatment response. Comparative and correlation analyses were performed between body composition metrics and clinical parameters. Results Patients who achieved full recovery exhibited significantly higher TAMA, PsoA, and SMI values compared to those with partial recovery (p < 0.05). These findings suggest that preserved muscle mass and quality are associated with a better response to biological therapy in AS. Conclusion Opportunistic CT-based body composition analysis provides valuable prognostic information in AS. SMI, TAMA, and psoas muscle volume may serve as potential imaging biomarkers for predicting biological treatment response, supporting personalized management strategies. Key Point Quantitative assessment of abdominal muscle metrics on routine CT can offer a non-invasive and accessible tool for predicting biological treatment outcomes in ankylosing spondylitis.